Adequate lymph node (LN) evaluation is important for planning treatment in patients with colon cancer. Aims of this study were to identify factors associated with adequate nodal examination and to determine its relationship with stage distribution and survival.
Introduction
Similar to other Western countries, colon cancer is frequently diagnosed in the Netherlands. Approximately 7,500 new cases of colon cancer were diagnosed in 2006. 1 Adequate lymph node (LN) analysis is important for planning treatment in patients with colon cancer as the result of randomised controlled trials showed that addition of chemotherapy significantly improves survival among patients with positive LNs. 2;3 Large variations in the number of evaluated LNs have been described. [4] [5] [6] These variations can be attributed to three factors: 1) patient factors (e.g. differences in the immune response of patients, anatomic or individual variability in nodal harvest), 2) surgical factors (e.g. surgeon volume, the extent of the surgical lymphadenectomy) and 3) pathological factors (e.g. the intensity of the examination of the pathologist, the technique used by the pathologist, examination by a pathologist versus pathology assistants). 5;7-12 A widely accepted standard of the number of LNs that should be evaluated is currently lacking. In literature, recommendations vary from 6 to 17 to as many as possible. [13] [14] [15] According to the guidelines of the International Union Against Cancer, usually ≥12 LNs are to be evaluated. 16 The Dutch colon cancer guidelines, revised in 2008, recommend a minimum of 10 negative LNs for accepting N0 status. 17 Still, adequate LN evaluation is lacking in a relatively large proportion of patients. 4;18 This may result in under-staging of tumours and subsequent under-treatment of patients. Improvement of LN examination could improve quality of care and likely increase survival. Therefore, the proportion of patients with a minimum number of LNs investigated is often suggested as a quality indicator for colon cancer. 19;20 The present study is a nationwide population-based study that describes the variation in LN examination, identifies factors associated with adequate LN evaluation and determines its relationship with stage distribution and survival.
Methods

Netherlands Cancer Registry
In the Netherlands, all newly diagnosed in situ and invasive tumours are registered in the nationwide population-based Netherlands Cancer Registry (NCR). Main sources of notification are the automated pathological archive (PALGA) and the Haematology Departments. Furthermore, the National Registry of Hospital Discharge Diagnoses is an important source, which accounts for up to 8% of new cases. 21 Data are collected from the patient files in the hospital by specially trained registration clerks and are coded according to a national manual. Information on patient characteristics, tumour characteristics, pathology laboratory, treatment, hospital of diagnosis, hospital of treatment and follow-up is recorded. The International Classification of Diseases for Oncology is used for coding topography and morphology. 22 Cancers are staged according to the TNM classification. 16 Quality of the data is high. 23 The completeness is estimated to be at least 95%. 24 Follow-up for all patients is complete up to January 2008 by linking the NCR to the municipality registry. Because of privacy regulations, death certificates are not available in an identifiable form to the cancer registry.
Patients
In this study, all patients who underwent surgical resection for stages I-III colon carcinoma (pT1-4NanyM0) and diagnosed in the period 2000-2006, were selected from the NCR (N=33,206 tumours). Patients who only underwent polypectomy or another local resection were excluded. Tumour site was divided into right-sided (C18.0-C18.5), leftsided (C18.6-C18.7) and unknown (C18.8-C18.9). Similar to the fifth edition of the TNM Atlas, patients in whom all the evaluated LNs were negative were considered as pN0, irrespective of the number of evaluated LNs. 16 
Hospitals, pathology laboratories and regions
Type of hospital was based on the hospital where the surgery was carried out. A teaching hospital was defined as a hospital that provides medical training to surgical residents. There is one specialised oncology centre in the Netherlands. This centre was classified as an academic hospital. A teaching pathology laboratory was a laboratory that provides medical training to pathology residents. Type of hospital and type of pathology laboratory were combined into one variable, resulting in six different groups. Surgery was carried out in 97 different hospitals and LN evaluation was done by 58 different pathology laboratories. Most pathology laboratories serve more than one hospital.
Volume of the pathology laboratory was based on the average number per year according to our study population.
Statistical analyses
Patients with no examined LNs (N=1,131) were excluded from all analyses, because certain factors (older age of the patient, acute resection, T1 tumour) might have led to a resection without lymphadenectomy. Correlation between number of evaluated LNs and nodal involvement and volume of the pathology laboratory was calculated by the Spearman's rank correlation test. LN ratio, determined by dividing the number of positive LNs by the total number of examined LNs, was split into quartiles with cut-off points at 0.140, 0.273 and 0.500.
Multilevel logistic analysis was carried out to examine the influence of gender, age at diagnosis, year of diagnosis, tumour site, depth of invasion, LN involvement, grade, type of hospital and type of pathology laboratory on the number of evaluated LNs. Multilevel analysis takes into account a hierarchical structure. Our data had a three-level data structure: tumours were clustered within hospitals of surgery, and hospitals of surgery were clustered within pathology laboratories. The magnitude of the variance of a level in combination with its standard error (SE) can be used as a rough test for judging significance of the variance. The dependency of observations within a certain level was estimated by the intraclass correlation coefficient (ICC). In a logistic multilevel analysis, the ICC can be estimated by: between-group variance / between-group variance + (p 2 / 3). 25 First, a null model without any variables was estimated. Second, patient and tumour characteristics were added stepwise to the model. 
Results
In Table 1 , the numbers of evaluated LNs by nodal involvement are listed. In total, the number of LNs examined could be determined for 30,682 (92%) patients. In 3% of all patients, no LNs were examined (pNX); these patients were excluded from further analyses. There were no large differences between hospitals in proportion of patients without evaluated LNs, with proportions ranging from 8.3% to 12.0% in five hospitals with the highest proportions. Ten or more LNs were examined in 35% of the patients with pN0 and in 44% of the patients with pN+ (in 38% of all patients). This proportion increased over time, from 24% in 2000 to 52% in 2006 in patients with pN0 and from 31% to 62% in patients with pN+. The median number of evaluated LNs was eight for the total study population; eight for patients with pN0 and nine for patients with pN+ (Table 2 ). The median number of evaluated LNs was the highest for patients operated in an academic hospital and of whom the resection specimen was subsequently analysed in an academic pathology laboratory. Figure 1 shows the median number of evaluated LNs by volume and type of pathology laboratory. The highest median number of examined LNs was found in low-volume departments of pathology (ρ=-0.08; P<0.001). All academic pathology laboratories had low case volumes.
In Figure 2 , the median number of evaluated LNs by pathology laboratory and the pro- The proportion of patients who had any LNs examined, but of whom the exact number was not stated in the pathology report also differed between the pathology laboratories.
In the whole study population, the proportion of patients with an unknown number of evaluated LNs was 6% in patients with pN0 and 7% in patients with pN+ (7% in all patients, range 0% to 41%). In Comparing the variances of the levels in the null model of the multilevel analysis with its own SE, both the variance of the hospital level and the variance of the pathology laboratory level were significant. This indicates that the variation between these levels cannot be ignored. The ICC of the hospital level was 0.031 and of the pathology laboratory level was 0.064, meaning that 3.1% of the total variance could be attributed to the hospital level and 6.4% to the pathology laboratory level.
After adding patient and tumour characteristics, females, younger patients, right-sided tumours, tumours with larger depth of invasion and with LN involvement were less likely to have nine or less LNs evaluated ( Table 3) (Table 4 ).
In Overall, pathology laboratories with the lowest mean number of evaluated LNs had a higher risk of death compared with pathology laboratories with the highest mean number of evaluated LNs after adjustment for relevant factors (HR 1.11, 95% CI 1.05-1.19 ).
Discussion
The results of this nationwide study show an increasing proportion of patients with positive nodes with increasing median number of evaluated LNs. A Dutch regional population-based study already described a large variation in LNs examination between the pathology laboratories in the south of the Netherlands. 5 Our study confirmed this variation for the entire Netherlands. Furthermore, we determined the influence of type of hospitals and type and volume of pathology laboratories. It seems that there are important differences between pathology laboratories in techniques or degree of diligence in examining specimens for LNs. Our results, however, also showed variation in adequate LN evaluation between hospitals, suggesting that adequate LN evaluation depends on the efforts of the surgical teams as well as the pathology team. If an excision is not wide enough, it is not possible for the pathologist to sample a sufficient number of LNs.
Therefore, surgeons and pathologists have to collaborate and work as a team. Another study, using data from the population-based registry SEER (Surveillance, Epidemiology and End Results), showed variation in LN retrieval by patient geographic location as well, confirming the effect of local surgery and pathology practice patterns on LN evaluation. 4 As in the present study, two Canadian studies, showed that surgery in a teaching hospital predicted a higher LN count. 26;27 They suggested that this could be a reflection of increased resources available, in both teaching hospitals and pathology laboratories and academic hospitals and pathology laboratories, to provide quality multidisciplinary cancer care. The lower chance of inadequate LN examination in an academic department of pathology might relate to the supervision on the work of the pathology residents in these departments. Another explanation could be the workload. The detection of LNs is a labour intensive and time-consuming process. Low-volume departments of pathology, which are among others all academic departments, have the highest median number of evaluated LNs. In line with this, a study in Ontario found that lack of time was a barrier to adequate LN assessment. More than 40% of the pathologists thought that it would be an increase in workload to identify five extra LNs per specimen. 28 A single-institution study found no association between LN harvest and the volume of the pathologists. 9 Other studies suggested differences in surgeon volume and extent of the dissection by different surgeons as explanation for the variation in examined LNs. 9;12;29 Unfortunately, no detailed information on surgeon or pathologist level was available on a national basis.
The association between LN retrieval and survival found in our study confirms the results of previous studies. 10;30-32 This phenomenon could partly be explained by under-staging: patients with a small number of evaluated LNs may be incorrectly seen as node negative. However, the also decreasing risk of death by number of evaluated LN in patients with node positive disease shows that there has to be another explanation as well. The number of LNs examined may also reflect the differences in the biological behaviour of the tumour and host. Patients with fewer LNs evaluated may be those who have a reduced local immune response to their tumour leading to smaller LNs, which are difficult to detect. 33 This reduced immune response itself might be related to an inferior prognosis. 34 Others suggested that the relation between higher LN counts and better survival reflects the quality of surgical resection. 30 Surgeons may have carried out a more extended lymphadenectomy, with resection of any (micro-)metastases in the LNs or in the surrounding mesocolic tissue. This could partly explain the differences in survival between pathology laboratories.
Comparable to our study, several studies showed that LN ratio is an important prognostic factor for patients with stage III colon carcinoma. 30;32;35-37 When grouped according to N stage, a patient with 2 positive LNs out of 40 examined LNs is in the same prognostic group as a patient with 2 positive LNs out of 2 examined LNs. LN ratio makes a distinction between the prognosis for these patients. 36 A randomised control trial demonstrated that a formal lecture by an expert opinion leader was associated with an increase in the number of evaluated LNs. 38 Feedback about performance can also be effective in improving professional practice. Medical specialists would probably change their practice when their performance is worse then their colleagues or when it is inconsistent with the guidelines. 39 The increase in number of examined LNs by year of diagnosis in our data might be an effect of feedback to the medical specialists in multidisciplinary working groups. 40 In 2002, a lot of attention was paid to LN evaluation with feedback to all the departments of pathology as a result of the Dutch Total Mesorectal Excision trial.
Patients with stage II and <10 examined LNs are, according to the Dutch guidelines, defined as patients with high risk. Adjuvant chemotherapy should be considered for this group. 17 Apart from avoiding the burden of the chemotherapy for the patient, a decreased proportion of patients with an inadequate LN evaluation could also lead to a reduction in expenses for chemotherapy. 40 Not only the number of evaluated LNs could be improved by the pathology laboratories, some pathology laboratories need to improve the quality of the pathology report as well.
According to the Dutch guidelines for colon cancer, the number of excised LNs is a compulsory item in a pathology report. 17 In our study, the proportion of patients with an unknown number of examined LNs (N=2,173; 7% of the study population) ranged from 0% to 41%, although we found an improvement over time. Similar to our results, a study of Jestin et al. 41 found the same survival rates of the patients for whom the number of examined LNs was not stated in the pathology report as that of patients with <12
LNs examined, suggesting that the quality of the pathology reports is an important factor for adequate staging.
In conclusion, we found a large diversity in LN evaluation with unexplained variation between hospitals and pathology laboratories, leading to differences in stage distribution and being associated with survival. To improve LN examination, surgeons and pathologists should work as a team. This will improve staging, leading to better treatment. 
